 NEW YORK, July 30, 2021 PRNewswire -- DLA Piper represented Cowen and Company, LLC, Stifel, Nicolaus Company, Incorporated and William Blair Company, L.L.C., as underwriters in the initial US public offering of 13,500,000 shares of common stock of MaxCyte, Inc. Nasdaq: MXCT LSE: MXCT, MXCN, a leading provider of cell-engineering platform technologies, at an initial offering price of US13.00 per share. 